The Wold Health Organisation has granted approval on June 1 to China's second COVID-19 vaccine, Sinovac, which was expected to strengthen China's vaccine diplomacy.
According to the findings of the phase 1/2 randomised clinical trial, published in The Lancet Infectious Diseases journal, the vaccine candidate could induce an antibody response in participants within 28 days of the first immunisation, by giving two doses 14 days apart.
'Viral infections rise in winter and better care needs to be taken in the next few months.'
Australia's medicines and medical devices regulator on Monday formally recognised India's Covaxin, a vaccine against the coronavirus as the country's border was reopened for the first time in nearly 20 months.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
Take our quiz to find out just how much of a news wiz you are.
'All the vaccines that are available in most countries, right now, are all highly effective and safe.'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances